pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-202 |
Genomic Coordinates | chr10: 133247511 - 133247620 |
Synonyms | MIRN202, hsa-mir-202, MIR202 |
Description | Homo sapiens miR-202 stem-loop |
Comment | The mature sequence shown here represents the most commonly cloned form from large-scale cloning studies . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-202-3p | ||||||||||||||||||||||||
Sequence | 64| AGAGGUAUAGGGCAUGGGAA |83 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NHLRC3 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | NHL repeat containing 3 | ||||||||||||||||||||
Transcript | NM_001012754 | ||||||||||||||||||||
Other Transcripts | NM_001017370 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NHLRC3 | |||||||||||||||||||||
3'UTR of NHLRC3 (miRNA target sites are highlighted) |
>NHLRC3|NM_001012754|3'UTR 1 TGTTTCTTTCCTGGGAATATTTCAAGTGGCAGTTCAGATTCTCAATTCACTAAGTGCTTAAAAATGATGTTCAAGCACAA 81 GAATTTATTTTTCTAGTATAAAAGATCTAGTATCAGAAAGATTTGTTTTTGTATCATTAAGAATCTTATATTTTGTTGCC 161 CTCTTGGGACTTAGTTTTATTTGTAAGTGCATAAGGATATTTTAATGAAAGGAAAGTAACTAAAAAATGGGGTTGGGAAG 241 AGGGACTAAGGTGGTAACCTCATTATTTGCCCTGGTAGACTGATTCTCCCTGGGTAAAAAAAATGGGAATAAAAATGAGC 321 TTGCATGATAATTTATTAAATTTCATGTGAAGAACTCCAGACCTCCAGATTGTGCAACTAACATAAAATGAGCTGCTTGA 401 GAGATTGTAAATAAGATGAACTATTGATTAATTTGAGTACCCACAGAGTGCTGTGTCTTGACGACTTAAAAATGAAAAAG 481 CAGGATTGCCTTTTGAGTAGCTTGCAGTCTAGTGGGGAGACAAGCAGGCAAACAGTCACAACACAGCAAAAGCGACCTTG 561 GAGCATAGTGGGACTTTTGGAGTAGGAGTGCTGCATTTGACTGAGGGAATCATGGATACTTCGCAGGAGAAGTGAATTTG 641 AGCTCAGACTTGAAAACTGAGGAGGAGCTTACCAAGGGACAAGGAGGAGAAAACAATAATTTCCAAGTAAAGAAGGTATA 721 AAAAGTTAGAAGTGTACTGTAAACTTTGATAGGCTTTTAGGCCTTTTTTAAAGCCCAACTTGGCTTCTGTCCATTACCTA 801 TAAGATATTTAATGTCAGTCAGCCTTTAAATGTAGGAATAAAATGGCTGGCATCTAAGCACTTTAGTAAAAGAGGTTTTT 881 ACAAATAACTAAGGATTGTAGAGCTTCCTTCTCTTTTTTTTTCTTTTTCTTTCTTTTGTTTTACATGAACTCAACTTATT 961 CCTAACATTTGTCTACCTCAAAGAAATTTCAAGATTATTTAGATAACATGGATATGTGCCAAATCCTTTGAGCTGTTAAG 1041 ATGATAATTTCCTGCTTTCCTCCTACATCTTCTCCTCCCACTCCCTCCTTTGGTGTGAATATTGGCTTCCCAATTAAGAC 1121 CTTTTTTTTTTTTTTTCCAGTTTGTTTTAGCTTATTATAGGTTTTGGAGGAACTTTGCCATTTTGTAATCTTTCAAATCA 1201 TTCTTCACCCTTCCTCACATCAGCTTCCTGCTTTTCCCAGTGTTTTACTGTAAATTGTGTAGCATATGACAAATCTTGAG 1281 CTGACTTTCCTCTTCACCTGTTATGGCTGGAGTATTTTCCAGACCTGAAGGGACTCACACTTGTTTTGATACTTGGATCA 1361 CATCTCCGTGAGGTTAGGAAGGTAAATCTACCAACAGGAAGCCCTGTACTCTGTATTCCAAGGCCATTGGTAAATGTGTT 1441 GGTGCCACTGATCGGACTGTATGACCTTAAACAAGTCACCTTAGTTTTCAGTGAAATGGGAATATCATTGTCTCCTCTTT 1521 CATGAATGCTGTGAGAATCAGATGTGCAACAGGTACAGACTTGCCCTTTGAAATCTATACCTCTGGATACATTAGAGGCA 1601 TTTTATTAACAAAGGCCCTTCTAAATGTGCTATTTATTTGACAATAACTATCAGATTTGCCTTAATTTTGTGTTTATAGC 1681 ATTTATCAAAACGTATCCTCATAGACTTTATGCAGATTAATATGGTCAATTGATTTGGATAAAAGAAAGTAATTTCAGGG 1761 TTTGTTTTTAAGCCAGGACAAGAAGTGCAAATGCCTCTTTGAAGCAATTTAGGCTAAACTGATTTTGAAATTTCAAAATG 1841 TTTTATTTTACTTTGTTTTATTAAGCCAGGACAAGAAGTGCAAATGCCTCTTTGAAGCAATTCAGGCTAGGTAAACCGAT 1921 TTTGCCATTTCAAAACGTTTTATTTTACTTTGTTTTATATCAGAGTCTTATAAAACCTGCTGCAAATATTTCTGAATGTC 2001 TTTGTAAAAGTGTTTGTTAGTGTACCTGTGATTATAGTACTTCACTTTTTTCCTTTGGATTAATTGGTTAAATGAATGAG 2081 AAATGTGTTATGTTTTTTACTAAAAAGTATAAATTAAAATTTTGGAAAGAAAAGGCAATATTATCTGGCTCCCCAATTAA 2161 AGTTTGATTTTATTGTCACAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 387921.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000470258.1 | 3UTR | AACUCAACUUAUUCCUAACAUUUGUCUACCUCAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000470258.1 | 3UTR | AACUCAACUUAUUCCUAACAUUUGUCUACCUCAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000470258.1 | 3UTR | AACUCAACUUAUUCCUAACAUUUGUCUACCUCAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
187 hsa-miR-202-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT016613 | MYCN | MYCN proto-oncogene, bHLH transcription factor | 1 | 1 | ||||||||
MIRT053565 | GLI1 | GLI family zinc finger 1 | 3 | 1 | ||||||||
MIRT063201 | ADIPOR2 | adiponectin receptor 2 | 2 | 2 | ||||||||
MIRT067406 | TMTC3 | transmembrane and tetratricopeptide repeat containing 3 | 2 | 2 | ||||||||
MIRT068548 | NHLRC3 | NHL repeat containing 3 | 2 | 6 | ||||||||
MIRT080404 | ONECUT2 | one cut homeobox 2 | 2 | 2 | ||||||||
MIRT118591 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT123324 | CALU | calumenin | 2 | 2 | ||||||||
MIRT191784 | LIN52 | lin-52 DREAM MuvB core complex component | 2 | 2 | ||||||||
MIRT194243 | FAM103A1 | family with sequence similarity 103 member A1 | 2 | 6 | ||||||||
MIRT252856 | ZNF526 | zinc finger protein 526 | 2 | 4 | ||||||||
MIRT268844 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 2 | ||||||||
MIRT273603 | SP1 | Sp1 transcription factor | 2 | 2 | ||||||||
MIRT363747 | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 | 2 | 2 | ||||||||
MIRT437760 | HAS2 | hyaluronan synthase 2 | 1 | 1 | ||||||||
MIRT437971 | LRP6 | LDL receptor related protein 6 | 3 | 1 | ||||||||
MIRT438223 | ARL5A | ADP ribosylation factor like GTPase 5A | 2 | 1 | ||||||||
MIRT442013 | NDUFA4P1 | NDUFA4, mitochondrial complex associated pseudogene 1 | 2 | 2 | ||||||||
MIRT445652 | ATP6V1G1 | ATPase H+ transporting V1 subunit G1 | 2 | 6 | ||||||||
MIRT448241 | ZNF774 | zinc finger protein 774 | 2 | 2 | ||||||||
MIRT452085 | NUCB2 | nucleobindin 2 | 2 | 2 | ||||||||
MIRT454158 | HIST1H2BK | histone cluster 1 H2B family member k | 2 | 2 | ||||||||
MIRT454273 | FXN | frataxin | 2 | 2 | ||||||||
MIRT455669 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT458010 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT458272 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT463411 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463655 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT465107 | TSC22D2 | TSC22 domain family member 2 | 2 | 4 | ||||||||
MIRT470409 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 2 | ||||||||
MIRT470662 | POLR2D | RNA polymerase II subunit D | 2 | 4 | ||||||||
MIRT470842 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT471411 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT471519 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT472668 | NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit | 2 | 2 | ||||||||
MIRT473124 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT474252 | LATS2 | large tumor suppressor kinase 2 | 2 | 2 | ||||||||
MIRT474485 | KLHDC8B | kelch domain containing 8B | 2 | 2 | ||||||||
MIRT474753 | KIAA0930 | KIAA0930 | 2 | 2 | ||||||||
MIRT474899 | KCTD21 | potassium channel tetramerization domain containing 21 | 2 | 2 | ||||||||
MIRT476815 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT477669 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT477739 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT479745 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT480332 | C5orf51 | chromosome 5 open reading frame 51 | 2 | 10 | ||||||||
MIRT481188 | ATXN7L3B | ataxin 7 like 3B | 2 | 4 | ||||||||
MIRT481228 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT481357 | ATG9A | autophagy related 9A | 2 | 2 | ||||||||
MIRT481645 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT485486 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT490467 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT492050 | TNFSF9 | TNF superfamily member 9 | 2 | 2 | ||||||||
MIRT492621 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT494680 | ARID3A | AT-rich interaction domain 3A | 2 | 2 | ||||||||
MIRT497868 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT498111 | PLEKHO1 | pleckstrin homology domain containing O1 | 2 | 4 | ||||||||
MIRT498793 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT499342 | RAB25 | RAB25, member RAS oncogene family | 2 | 2 | ||||||||
MIRT499398 | PLCG2 | phospholipase C gamma 2 | 2 | 4 | ||||||||
MIRT499646 | SDR42E1 | short chain dehydrogenase/reductase family 42E, member 1 | 2 | 2 | ||||||||
MIRT500805 | THBS1 | thrombospondin 1 | 2 | 3 | ||||||||
MIRT501194 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT501225 | SEMA4C | semaphorin 4C | 2 | 6 | ||||||||
MIRT501317 | RNFT1 | ring finger protein, transmembrane 1 | 2 | 2 | ||||||||
MIRT501341 | RNF44 | ring finger protein 44 | 2 | 4 | ||||||||
MIRT501381 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 10 | ||||||||
MIRT501683 | PDE12 | phosphodiesterase 12 | 2 | 8 | ||||||||
MIRT501923 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT501933 | MBD2 | methyl-CpG binding domain protein 2 | 2 | 8 | ||||||||
MIRT502118 | KMT2D | lysine methyltransferase 2D | 2 | 4 | ||||||||
MIRT502260 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 2 | 2 | ||||||||
MIRT502766 | CLDN12 | claudin 12 | 2 | 6 | ||||||||
MIRT502831 | CELF1 | CUGBP Elav-like family member 1 | 2 | 2 | ||||||||
MIRT505007 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT505571 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT506930 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT507238 | FIGN | fidgetin, microtubule severing factor | 2 | 8 | ||||||||
MIRT507680 | COIL | coilin | 2 | 6 | ||||||||
MIRT508394 | C1orf210 | chromosome 1 open reading frame 210 | 2 | 6 | ||||||||
MIRT508658 | DIABLO | diablo IAP-binding mitochondrial protein | 2 | 4 | ||||||||
MIRT508925 | AK4 | adenylate kinase 4 | 2 | 4 | ||||||||
MIRT510382 | ZNF566 | zinc finger protein 566 | 2 | 6 | ||||||||
MIRT511379 | IKZF3 | IKAROS family zinc finger 3 | 2 | 4 | ||||||||
MIRT512738 | CD59 | CD59 molecule (CD59 blood group) | 2 | 4 | ||||||||
MIRT516076 | ZBTB8OS | zinc finger and BTB domain containing 8 opposite strand | 2 | 4 | ||||||||
MIRT520035 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT521379 | RDX | radixin | 2 | 4 | ||||||||
MIRT523609 | FZD9 | frizzled class receptor 9 | 2 | 4 | ||||||||
MIRT523970 | DVL3 | dishevelled segment polarity protein 3 | 2 | 2 | ||||||||
MIRT524100 | DNA2 | DNA replication helicase/nuclease 2 | 2 | 2 | ||||||||
MIRT525720 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT529720 | OPRL1 | opioid related nociceptin receptor 1 | 2 | 2 | ||||||||
MIRT533174 | WASL | Wiskott-Aldrich syndrome like | 2 | 6 | ||||||||
MIRT536371 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT541383 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT542687 | SALL3 | spalt like transcription factor 3 | 2 | 2 | ||||||||
MIRT543861 | SLC16A9 | solute carrier family 16 member 9 | 2 | 2 | ||||||||
MIRT545380 | PM20D2 | peptidase M20 domain containing 2 | 2 | 2 | ||||||||
MIRT545851 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT545877 | ZNF200 | zinc finger protein 200 | 2 | 4 | ||||||||
MIRT546322 | TGFBR3 | transforming growth factor beta receptor 3 | 2 | 2 | ||||||||
MIRT546645 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT547363 | MSI2 | musashi RNA binding protein 2 | 2 | 2 | ||||||||
MIRT547564 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT547828 | IGF2BP3 | insulin like growth factor 2 mRNA binding protein 3 | 2 | 4 | ||||||||
MIRT548258 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT548331 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT548526 | DUSP1 | dual specificity phosphatase 1 | 2 | 2 | ||||||||
MIRT549016 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT549200 | BEND4 | BEN domain containing 4 | 2 | 4 | ||||||||
MIRT549756 | ZNF611 | zinc finger protein 611 | 2 | 6 | ||||||||
MIRT549792 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT549840 | ECHDC1 | ethylmalonyl-CoA decarboxylase 1 | 2 | 2 | ||||||||
MIRT550720 | PMPCA | peptidase, mitochondrial processing alpha subunit | 2 | 4 | ||||||||
MIRT550891 | ACTA1 | actin, alpha 1, skeletal muscle | 2 | 2 | ||||||||
MIRT551276 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | 2 | 6 | ||||||||
MIRT551311 | GSG2 | histone H3 associated protein kinase | 2 | 6 | ||||||||
MIRT551925 | AKAP8 | A-kinase anchoring protein 8 | 2 | 4 | ||||||||
MIRT552403 | ZNF460 | zinc finger protein 460 | 2 | 4 | ||||||||
MIRT552463 | ZNF280B | zinc finger protein 280B | 2 | 2 | ||||||||
MIRT555533 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT555692 | PEX11B | peroxisomal biogenesis factor 11 beta | 2 | 2 | ||||||||
MIRT555697 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT556036 | MXD1 | MAX dimerization protein 1 | 2 | 2 | ||||||||
MIRT556264 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT557366 | HAND1 | heart and neural crest derivatives expressed 1 | 2 | 2 | ||||||||
MIRT557947 | FAM222B | family with sequence similarity 222 member B | 2 | 2 | ||||||||
MIRT558792 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT561769 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT564395 | EMILIN2 | elastin microfibril interfacer 2 | 2 | 4 | ||||||||
MIRT565223 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT565437 | SURF4 | surfeit 4 | 2 | 2 | ||||||||
MIRT566494 | PBX2P1 | PBX homeobox 2 pseudogene 1 | 2 | 2 | ||||||||
MIRT566511 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT567315 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 2 | 2 | ||||||||
MIRT567708 | E2F6 | E2F transcription factor 6 | 2 | 2 | ||||||||
MIRT568320 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT568644 | ABHD17C | abhydrolase domain containing 17C | 2 | 2 | ||||||||
MIRT569491 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT573813 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT574356 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT574744 | GOLGA4 | golgin A4 | 2 | 2 | ||||||||
MIRT576071 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576789 | Thbs1 | thrombospondin 1 | 2 | 3 | ||||||||
MIRT616363 | RWDD1 | RWD domain containing 1 | 2 | 2 | ||||||||
MIRT642387 | ZNF556 | zinc finger protein 556 | 2 | 2 | ||||||||
MIRT650257 | ARHGAP22 | Rho GTPase activating protein 22 | 2 | 2 | ||||||||
MIRT680512 | PRIM2 | DNA primase subunit 2 | 2 | 2 | ||||||||
MIRT680540 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT680831 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT681264 | RFC2 | replication factor C subunit 2 | 2 | 2 | ||||||||
MIRT681352 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT681499 | STAT2 | signal transducer and activator of transcription 2 | 2 | 2 | ||||||||
MIRT681529 | ZNF738 | zinc finger protein 738 | 2 | 2 | ||||||||
MIRT681651 | DTX3L | deltex E3 ubiquitin ligase 3L | 2 | 2 | ||||||||
MIRT681755 | CDKAL1 | CDK5 regulatory subunit associated protein 1 like 1 | 2 | 2 | ||||||||
MIRT681790 | EIF4A3 | eukaryotic translation initiation factor 4A3 | 2 | 2 | ||||||||
MIRT681935 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT682095 | ITGA3 | integrin subunit alpha 3 | 2 | 4 | ||||||||
MIRT682174 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT682231 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT682378 | PHACTR4 | phosphatase and actin regulator 4 | 2 | 2 | ||||||||
MIRT682589 | CPA4 | carboxypeptidase A4 | 2 | 2 | ||||||||
MIRT682633 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 2 | ||||||||
MIRT689320 | FPR1 | formyl peptide receptor 1 | 2 | 2 | ||||||||
MIRT689723 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT691029 | ZNF799 | zinc finger protein 799 | 2 | 2 | ||||||||
MIRT691928 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 2 | ||||||||
MIRT694877 | ZNF417 | zinc finger protein 417 | 2 | 2 | ||||||||
MIRT695248 | ZNF443 | zinc finger protein 443 | 2 | 2 | ||||||||
MIRT701422 | NHLRC2 | NHL repeat containing 2 | 2 | 2 | ||||||||
MIRT701992 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT702477 | KIAA1328 | KIAA1328 | 2 | 2 | ||||||||
MIRT702701 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT704022 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT712363 | NAP1L1 | nucleosome assembly protein 1 like 1 | 2 | 2 | ||||||||
MIRT712448 | KHNYN | KH and NYN domain containing | 2 | 2 | ||||||||
MIRT713513 | PAFAH2 | platelet activating factor acetylhydrolase 2 | 2 | 2 | ||||||||
MIRT731769 | PDCD4 | programmed cell death 4 | 3 | 1 | ||||||||
MIRT733048 | TLR4 | toll like receptor 4 | 1 | 0 | ||||||||
MIRT733831 | BDNF | brain derived neurotrophic factor | 3 | 0 | ||||||||
MIRT737334 | HK2 | hexokinase 2 | 3 | 0 | ||||||||
MIRT756084 | MMP11 | matrix metallopeptidase 11 | 3 | 1 | ||||||||
MIRT756086 | FN1 | fibronectin 1 | 2 | 1 | ||||||||
MIRT756087 | COL6A1 | collagen type VI alpha 1 chain | 2 | 1 | ||||||||
MIRT756088 | COL6A2 | collagen type VI alpha 2 chain | 2 | 1 | ||||||||
MIRT756089 | COL6A3 | collagen type VI alpha 3 chain | 2 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|